Supernus Pharmaceuticals
SUPN
SUPN
320 hedge funds and large institutions have $3.21B invested in Supernus Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 112 increasing their positions, 120 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
320
Holders Change
+8
Holders Change %
+2.56%
% of All Funds
7.34%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.16%
New
46
Increased
112
Reduced
120
Closed
37
Calls
$16.7M
Puts
$33.2M
Net Calls
-$16.5M
Net Calls Change
-$14.1M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$56.3M |
| 2 |
1832 Asset Management
Toronto,
Ontario, Canada
|
$48.3M |
| 3 |
BlackRock
New York
|
$460M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$48.2M |
| 5 |
Renaissance Technologies
New York
|
$52.9M |
